882 related articles for article (PubMed ID: 26247543)
1. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
2. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
[TBL] [Abstract][Full Text] [Related]
5. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract][Full Text] [Related]
6. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
[TBL] [Abstract][Full Text] [Related]
7. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.
Swanick CW; Lei X; Shaitelman SF; Schlembach PJ; Bloom ES; Fingeret MC; Strom EA; Tereffe W; Woodward WA; Stauder MC; Dvorak T; Thompson AM; Buchholz TA; Smith BD
Cancer; 2016 Sep; 122(18):2886-94. PubMed ID: 27305037
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
[No Abstract] [Full Text] [Related]
10. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
12. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
13. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
15. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
[TBL] [Abstract][Full Text] [Related]
16. Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.
Rudat V; Nour A; Ghaida SA; Alaradi A
Radiat Oncol; 2016 Jul; 11():100. PubMed ID: 27473272
[TBL] [Abstract][Full Text] [Related]
17. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
[TBL] [Abstract][Full Text] [Related]
18. Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network.
Rajagopalan MS; Flickinger JC; Heron DE; Beriwal S
Pract Radiat Oncol; 2015; 5(2):63-9. PubMed ID: 25748004
[TBL] [Abstract][Full Text] [Related]
19. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
20. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
